3.57

6.54% -0.25

Pre-market: 3.61 0.04 +1.12%

Personalis Inc (PSNL)

Overview News Price History Option Chain Financials Discussions Forecast

Personalis Inc stock is traded at $3.57, with a volume of 802.44K. It is down -6.54% in the last 24 hours and down -28.46% over the past month. Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.

Previous Close:

$3.82

Open:

$3.89

24h Volume:

802.44K

Relative Volume:

0.67

Market Cap:

$315.10M

Revenue:

$73.48M

Net Income/Loss:

$-108.30M

P/E Ratio:

-1.5867

EPS:

-2.25

Net Cash Flow:

$-67.17M

1W Performance:

-15.40%

1M Performance:

-28.46%

6M Performance:

-37.26%

1Y Performance:

+111.24%

1-Day Range:

$3.45

$3.9386

1-Week Range:

$3.38

$4.4259

52-Week Range:

$1.135

$7.20

Personalis Inc Stock (PSNL) Company Profile

Name

Personalis Inc

Sector

Healthcare (1169)

Industry

Diagnostics & Research (61)

Phone

650-752-1300

Address

6600 DUMBARTON CIRCLE, FREMONT, CA

Employee

229

Twitter

@PersonalisInc

Next Earnings Date

2024-11-06

Latest SEC Filings

PSNL's Discussions on Twitter

Compare PSNL with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
PSNL Personalis Inc	3.57	315.10M	73.48M	-108.30M	-67.17M	-2.25
TMO Thermo Fisher Scientific Inc	508.90	191.99B	42.88B	6.34B	7.27B	16.53
DHR Danaher Corp	204.09	145.87B	23.88B	3.90B	5.30B	5.28
A Agilent Technologies Inc	117.33	33.47B	6.53B	1.26B	1.31B	4.35
IDXX Idexx Laboratories Inc	406.29	33.04B	3.90B	887.87M	798.08M	10.67
IQV Iqvia Holdings Inc	181.43	31.99B	15.41B	1.37B	2.11B	7.50

Personalis Inc Stock (PSNL) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-06-23	Upgrade	Needham	Hold → Buy
Jan-07-22	Upgrade	BofA Securities	Neutral → Buy
Nov-05-21	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Nov-03-21	Downgrade	Needham	Buy → Hold
Oct-15-21	Resumed	Cowen	Outperform
Sep-20-21	Reiterated	Needham	Buy
May-06-21	Upgrade	Oppenheimer	Perform → Outperform
Jan-28-21	Initiated	Truist	Buy
Jan-04-21	Downgrade	BofA Securities	Buy → Neutral
Nov-12-20	Reiterated	Needham	Buy
Nov-06-20	Downgrade	Oppenheimer	Outperform → Perform
Oct-19-20	Initiated	Citigroup	Buy
Oct-08-20	Initiated	BTIG Research	Buy
Aug-27-20	Initiated	H.C. Wainwright	Buy
Aug-18-20	Initiated	Needham	Buy
Sep-26-19	Upgrade	BofA/Merrill	Neutral → Buy
Jul-15-19	Initiated	BofA/Merrill	Neutral
Jul-15-19	Initiated	Cowen	Outperform
Jul-15-19	Initiated	Morgan Stanley	Overweight
Jul-15-19	Initiated	Oppenheimer	Outperform

View All

Personalis Inc Stock (PSNL) Latest News

Mar 12, 2025

Hold Rating for Personalis: Balancing Strong Enterprise Sales and Future Uncertainties - TipRanks

Mar 12, 2025

Mar 08, 2025

Cathie Wood-Led Ark Invest Roblox, Roku, UiPath As Markets Take A Dip - Benzinga

Mar 08, 2025

Mar 07, 2025

Personalis Stock Price, Quotes and Forecasts | NASDAQ:PSNL - Benzinga

Mar 07, 2025

Mar 03, 2025

Personalis stock target cut to $7 by BTIG, maintains Buy rating - Investing.com Canada

Mar 03, 2025

New Publication from ICR and Royal Marsden Researchers Highlights the Importance of Ultra-Sensitive ctDNA Testing for Early-Stage Breast Cancer Recurrence Detection - Yahoo Finance

Mar 03, 2025

Personalis’ (PSNL) “Buy” Rating Reiterated at HC Wainwright - Defense World

Mar 03, 2025

Needham & Company LLC Cuts Personalis (NASDAQ:PSNL) Price Target to $7.00 - Defense World

Mar 03, 2025

Mar 02, 2025

Personalis, Inc. (NASDAQ:PSNL) Just Reported Earnings, And Analysts Cut Their Target Price - Simply Wall St

Mar 02, 2025

Mar 01, 2025

Personalis (NASDAQ:PSNL) Price Target Lowered to $7.00 at Needham & Company LLC - MarketBeat

Mar 01, 2025

Personalis Full Year 2024 Earnings: Beats Expectations - Yahoo Finance

Mar 01, 2025

Feb 28, 2025

Personalis (NASDAQ:PSNL) Announces Quarterly Earnings Results - MarketBeat

Feb 28, 2025

Personalis stock target cut to $7.00 at Needham, retains buy rating By Investing.com - Investing.com South Africa

Feb 28, 2025

Personalis (NASDAQ:PSNL) Announces Earnings Results, Beats Expectations By $0.09 EPS - MarketBeat

Feb 28, 2025

Personalis files to sell 14.04M shares of common stock for holders - MSN

Feb 28, 2025

Personalis stock target cut to $7.00 at Needham, retains buy rating - Investing.com Canada

Feb 28, 2025

Personalis, Inc. (NASDAQ:PSNL) Q4 2024 Earnings Call Transcript - Insider Monkey

Feb 28, 2025

A Glimpse Into The Expert Outlook On Personalis Through 7 Analysts - Benzinga

Feb 28, 2025